PTO Form 1963 (Rev 5/2006) |
OMB No. 0651-0055 (Exp 07/31/2018) |
Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9
The table below presents the data as entered.
Input Field
|
Entered
|
REGISTRATION NUMBER |
2948764 |
REGISTRATION DATE |
05/10/2005 |
SERIAL NUMBER |
76388649 |
MARK SECTION |
MARK |
SUTENT |
ATTORNEY SECTION (current) |
NAME |
Katrina Edge |
FIRM NAME |
Pfizer Inc. |
INTERNAL ADDRESS |
Trademarks Group |
STREET |
235 E. 42nd St. |
CITY |
New York |
STATE |
New York |
POSTAL CODE |
10017 |
COUNTRY |
United States |
PHONE |
2127334053 |
FAX |
2125732273 |
EMAIL |
deadlinesipnyo@pfizer.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
DOCKET/REFERENCE NUMBER |
T111743 |
ATTORNEY SECTION (proposed) |
NAME |
Katrina Edge |
FIRM NAME |
Pfizer Inc. |
INTERNAL ADDRESS |
Trademarks Group |
STREET |
235 E. 42nd St. |
CITY |
New York |
STATE |
New York |
POSTAL CODE |
10017 |
COUNTRY |
United States |
PHONE |
212-733-4053 |
FAX |
212-573-2273 |
EMAIL |
deadlinesipnyo@pfizer.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
DOCKET/REFERENCE NUMBER |
T111743-SUTENT |
OTHER APPOINTED ATTORNEY |
Richard A. Friedman Tiffany Trunko, Heather A. McDonald, Seana Smith, Katrina Edge, and Michelle Farber. |
CORRESPONDENCE SECTION (current) |
NAME |
Katrina Edge |
FIRM NAME |
Pfizer Inc. |
INTERNAL ADDRESS |
Trademarks Group |
STREET |
235 E. 42nd St. |
CITY |
New York |
STATE |
New York |
POSTAL CODE |
10017 |
COUNTRY |
United States |
PHONE |
2127334053 |
FAX |
2125732273 |
EMAIL |
deadlinesipnyo@pfizer.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
DOCKET/REFERENCE NUMBER |
T111743 |
CORRESPONDENCE SECTION (proposed) |
NAME |
Katrina Edge |
FIRM NAME |
Pfizer Inc. |
INTERNAL ADDRESS |
Trademarks Group |
STREET |
235 E. 42nd St. |
CITY |
New York |
STATE |
New York |
POSTAL CODE |
10017 |
COUNTRY |
United States |
PHONE |
212-733-4053 |
FAX |
212-573-2273 |
EMAIL |
deadlinesipnyo@pfizer.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
DOCKET/REFERENCE NUMBER |
T111743-SUTENT |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
GOODS OR SERVICES |
pharmaceutical preparation for the prevention and treatment of cancer |
SPECIMEN FILE NAME(S) |
ORIGINAL PDF FILE |
SPN0-1481689621-20150507144326940720_._SUTENT.pdf |
CONVERTED PDF FILE(S)
(3 pages) |
\\TICRS\EXPORT16\IMAGEOUT16\763\886\76388649\xml2\S890002.JPG |
|
\\TICRS\EXPORT16\IMAGEOUT16\763\886\76388649\xml2\S890003.JPG |
|
\\TICRS\EXPORT16\IMAGEOUT16\763\886\76388649\xml2\S890004.JPG |
SPECIMEN DESCRIPTION |
Patient Medication Guide identifying product and provided at time of subscription |
OWNER SECTION (current) |
NAME |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. |
STREET |
235 EAST 42ND STREET |
CITY |
NEW YORK |
STATE |
New York |
ZIP/POSTAL CODE |
10017 |
COUNTRY |
United States |
LEGAL ENTITY SECTION (current) |
TYPE |
limited partnership |
LEGAL ENTITY SECTION (proposed) |
TYPE |
limited partnership |
STATE/COUNTRY WHERE LEGALLY ORGANIZED |
Netherlands |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
NUMBER OF CLASSES PAID |
1 |
SUBTOTAL AMOUNT |
400 |
TOTAL FEE PAID |
400 |
SIGNATURE SECTION |
SIGNATURE |
/kedge/ |
SIGNATORY'S NAME |
Katrina Edge |
SIGNATORY'S POSITION |
Senior Corporate Counsel [MA bar member] |
DATE SIGNED |
05/07/2015 |
SIGNATORY'S PHONE NUMBER |
212.733.4053 |
PAYMENT METHOD |
DA |
FILING INFORMATION |
SUBMIT DATE |
Thu May 07 14:51:11 EDT 2015 |
TEAS STAMP |
USPTO/S08N09-XXX.XXX.XX.X
X-20150507145111466003-29
48764-5305d867ed476d1835f
9b6671b76c2ebfffe27587b0f
cea9aa51b5774eb7279ca-DA-
1002-20150507144326940720 |
PTO Form 1963 (Rev 5/2006) |
OMB No. 0651-0055 (Exp 07/31/2018) |
Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9
To the Commissioner for Trademarks:
REGISTRATION NUMBER: 2948764
REGISTRATION DATE: 05/10/2005
MARK: SUTENT
The owner, C.P. PHARMACEUTICALS INTERNATIONAL C.V., a limited partnership legally organized under the laws of Netherlands, having an address of
235 EAST 42ND STREET
NEW YORK, New York 10017
United States
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.
For International Class 005, the mark is in use in commerce on or in connection with
all goods/services, or to indicate membership in the collective membership organization, listed in the
existing registration for this specific class: pharmaceutical preparation for the prevention and treatment of cancer ; or, the owner is making the listed excusable nonuse claim.
The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) Patient Medication Guide identifying product
and provided at time of subscription.
Original PDF file:
SPN0-1481689621-20150507144326940720_._SUTENT.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3
The registrant's current Attorney Information: Katrina Edge of Pfizer Inc.
Trademarks Group
235 E. 42nd St.
New York, New York (NY) 10017
United States
The docket/reference number is T111743.
The registrant's proposed Attorney Information: Katrina Edge of Pfizer Inc.
Trademarks Group
235 E. 42nd St.
New York, New York (NY) 10017
United States
The docket/reference number is T111743-SUTENT.
The Other Appointed Attorney(s): Richard A. Friedman Tiffany Trunko, Heather A. McDonald, Seana Smith, Katrina Edge, and Michelle Farber..
The phone number is 212-733-4053.
The fax number is 212-573-2273.
The email address is deadlinesipnyo@pfizer.com.
The registrant's current Correspondence Information: Katrina Edge of Pfizer Inc.
Trademarks Group
235 E. 42nd St.
New York, New York (NY) 10017
United States
The docket/reference number is T111743.
The registrant's proposed Correspondence Information: Katrina Edge of Pfizer Inc.
Trademarks Group
235 E. 42nd St.
New York, New York (NY) 10017
United States
The docket/reference number is T111743-SUTENT.
The phone number is 212-733-4053.
The fax number is 212-573-2273.
The email address is deadlinesipnyo@pfizer.com.
A fee payment in the amount of $400 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.
Declaration
Section 8: Declaration of Use and/or Excusable Nonuse in Commerce
Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services identified above, as evidenced by the attached specimen(s)
showing the mark as used in commerce.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the
like may jeopardize the validity of this submission, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.
Section 9: Application for Renewal
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
Signature: /kedge/ Date: 05/07/2015
Signatory's Name: Katrina Edge
Signatory's Position: Senior Corporate Counsel [MA bar member]
Signatory's Phone Number: 212.733.4053
Mailing Address
(current):
Pfizer Inc.
235 E. 42nd St.
New York, New York 10017
Mailing Address
(proposed):
Pfizer Inc.
235 E. 42nd St.
New York, New York 10017
Serial Number: 76388649
Internet Transmission Date: Thu May 07 14:51:11 EDT 2015
TEAS Stamp: USPTO/S08N09-XXX.XXX.XX.XX-2015050714511
1466003-2948764-5305d867ed476d1835f9b667
1b76c2ebfffe27587b0fcea9aa51b5774eb7279c
a-DA-1002-20150507144326940720